ReoPro anti-platelet antibody: Update

Primary end point in the trial is death, myocardial infarction and urgent intervention at 30 days. Dose is an 0.25 mg/kg 10-60 minute bolus prior to angioplasty, followed by

Read the full 290 word article

How to gain access

Continue reading with a
two-week free trial.